Adoptive cell therapy in metastatic melanoma

preview_player
Показать описание
Maartje Rohaan, MD, Netherlands Cancer Institute, Amsterdam, The Netherlands, outlines her optimism about the use of adoptive cell therapy in metastatic melanoma, based off of both her own research and on what she heard at ESMO 2019. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.
Рекомендации по теме